Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors

Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong and Lisa A. Porter
Journal of Nuclear Medicine June 2020, 61 (6) 904-910; DOI: https://doi.org/10.2967/jnumed.119.231068
Martin K. Bakht
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
2Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica M. Lovnicki
4Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice Tubman
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith F. Stringer
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
5Department of Pathology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Chiaramonte
6Department of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Reynolds
6Department of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iulian Derecichei
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa-Maria Ferraiuolo
7Barbara Ann Karmanos Cancer Institute, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bre-Anne Fifield
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorota Lubanska
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
So Won Oh
2Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gi Jeong Cheon
2Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheol Kwak
8Department of Urology, Seoul National University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang Wook Jeong
8Department of Urology, Seoul National University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
2Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Trant
6Department of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colm Morrissey
9Department of Urology, University of Washington, Seattle, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilsa M. Coleman
10Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuzhuo Wang
4Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hojjat Ahmadzadehfar
11Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuesen Dong
4Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa A. Porter
1Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    AR-negative subsets of mCRPC in UW cohort (3) have suppressed expression of FOLH1 and differential expression of SLC2A and hexokinase genes. (A) Heat-map plot of expression levels of SLC2A family members, hexokinase genes, AR, FOLH1, and neuroendocrine markers sorted on the basis of nearest neighbors clustering to AR. (B, C, and D) Box–whisker plots showing expression of FOLH1, GCK, and SLC2A12, respectively.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    NELPC subset of Memorial Sloan Kettering Cancer Center cohort (24) displays shorter time to BCR (A), greater prevalence of metastatic and high Gleason score specimens (B), and lack of AR response (C). (D) Violin plots compare distribution of SLC2A12, GCK, and FOLH1 expressions in NELPC and AdPC subsets. BCR = biochemical recurrence; ES = enrichment score; FDR = false discovery rate.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    NEPC PDX models have suppressed expression of FOLH1 and differential expressions of SLC2A12 and GCK. (A) Transcription of studied genes during progression to NEPC and correlation with AR. (B) Expression of studied genes in PDX models.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Neuroendocrine-induced LNCaP cell line represents higher glucose uptake and differential protein levels of glucokinase and GLUT12. (A and B) Western blot analyses of protein levels. (C and D) Quantification of GB2-Cy3 uptake and representative images of LNCaP cells. Scale bar = 200 μm.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Neuroendocrine-induced LNCaP cell line xenografts represent higher glucose uptake in zebrafish model. (A) Schematic of experiment. (B and C) Quantification of GB2-Cy3 uptake and representative images of embryos injected with different LNCaP cells. Arrowheads show injection sites. Scale bar = 200 μm.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (6)
Journal of Nuclear Medicine
Vol. 61, Issue 6
June 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong, Lisa A. Porter
Journal of Nuclear Medicine Jun 2020, 61 (6) 904-910; DOI: 10.2967/jnumed.119.231068

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong, Lisa A. Porter
Journal of Nuclear Medicine Jun 2020, 61 (6) 904-910; DOI: 10.2967/jnumed.119.231068
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
  • The VISION Forward: Recognition and Implication of PSMA-/18F-FDG+ mCRPC
  • Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
  • The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer
  • Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
  • Google Scholar

More in this TOC Section

Theranostics

  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
  • 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Show more Theranostics

Basic

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Show more Basic

Similar Articles

Keywords

  • neuroendocrine PC
  • PSMA
  • glucose transporters
  • hexokinases
  • glucokinase
SNMMI

© 2025 SNMMI

Powered by HighWire